Vector Borne Diseases: Clinical Trials

43 trials for Vector Borne Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 unknown. 43 Phase 2, 7 Phase 1, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 243Unknown 43
Phase 17Unknown 7
Phase 36Unknown 6

Follow Vector Borne Diseases: new trials by email Literature Review of Vector Borne Diseases trials Research Report on Vector Borne Diseases

Trials (filtered) newest first · largest first

All 43 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sm-p80 Schistosomiasis Challenge Study
Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis
Phase 2UnknownLeiden University Medical Center482024-09-012023-10-17
Early Interferon-beta Treatment for West-Nile Virus Infection
Rebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline - West Nile Virus, West Nile Fever Encephalitis
Phase 2UnknownTel-Aviv Sourasky Medical Center1002024-07-142024-07-23
Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis
Oral tofacitinib, Parenteral meglumine antimoniate - Cutaneous Leishmaniasis, American
Phase 2 / Phase 3UnknownHospital Universitário Professor Edgard Santos222023-10-012023-08-25
Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome
Arm-2 : 2,00,000 IU Vitamin D3 oral solution , Arm-3: 4,00,000 IU Vitamin D3 oral solution - Dengue Fever
Phase 2UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1202023-06-012023-10-06
MSP3-CRM-Vac4All/ Alhydrogel® Vaccine
MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine - Malaria,Falciparum
Phase 1 / Phase 2UnknownVac4All4652023-03-272023-04-26
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity
Stamaril, Imojev, Ixiaro - Infectious Disease, Yellow Fever
Phase 2UnknownSingapore General Hospital702022-09-282023-04-12
Anti-Schistosomiasis Sm14-vaccine in Senegal
Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium
Phase 2UnknownOswaldo Cruz Foundation1202022-07-012022-12-21
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
Miltefosine 50mg, Pentoxifylline 400mg, Liposomal Amphotericin B - Leishmaniasis; Brazilian, Leishmaniasis, Mucocutaneous
Phase 2 / Phase 3UnknownUniversity of Brasilia1002022-06-222023-09-15
Emodepside Phase II Trial for Treatment of Onchocerciasis
emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis
Phase 2UnknownDrugs for Neglected Diseases5782021-08-302024-03-05
SBRT in Chagas Disease Ventricular Tachycardia
Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease
Phase 1 / Phase 2UnknownUniversity of Sao Paulo General Hospital102021-07-142024-07-16
Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers
Vaccine PvCS N+C+R 150 mcg, Placebo SSN Montanide ISA-51 1 mL - Malaria, Vivax
Phase 2UnknownMalaria Vaccine and Drug Development Center1202021-06-012021-03-01
Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients
18-Methoxycoronaridine, Glucantime - Leishmaniasis; American, Cutaneous, Drug Side Effect
Phase 2UnknownInfan Industria Quimica Farmaceutica Nacional522021-05-012020-03-19
Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension
Selexipag - Pulmonary Hypertension, Schistosomiasis
Phase 2UnknownUniversity of Sao Paulo General Hospital202020-10-152020-10-19
Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens
plague vaccine(F1+rV) - Plague
Phase 2UnknownJiangsu Province Centers for Disease Control and Prevention7202020-05-082022-04-15
Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections
Pyronaridine tetraphosphate 180mg:artesunate 60mg - Malaria,Falciparum
Phase 2UnknownShin Poong Pharmaceutical Co. Ltd.3002018-10-032019-09-30
Colchicine for Patients With Chagas´ Disease( B1 Stage)
Colchicine 0.5 MG twice day for one year, Placebo Oral Tablet - Chagas Disease, Colchicine Resistance
Phase 2UnknownUniversity of Sao Paulo General Hospital602018-10-012019-03-11
Triple Antimalarial Combination to Accelerate the Parasite Clearance and to Prevent the Selection of Resistant Parasites
Imatinib, Dihydroartemisinin-piperaquine - Plasmodium Falciparum Malaria (Drug Resistant)
Phase 2UnknownNurex S.r.l.502017-09-172018-10-05
BENDITA BEnznidazole New Doses Improved Treatment and Associations
Benznidazole, E1224, E1224 Placebo - Chagas Disease
Phase 2UnknownDrugs for Neglected Diseases2102016-11-302017-12-20
Plasmodium Immunotherapy for Lung Cancer
Blood-stage infection of P. vivax - Lung Cancer, Nonsmall Cell
Phase 1 / Phase 2UnknownState Key Laboratory of Respiratory Disease302016-06-272023-06-22
Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine
Western Equine Encephalitis (WEE) Vaccine - Western Equine Encephalitis
Phase 2UnknownU.S. Army Medical Research and Development Command5002015-12-152021-02-11

Showing 20 of 43. Sign in to see all of them.

Narrower conditions

Malaria (8)  ·  Chagas Disease (6)  ·  Dengue (5)  ·  Malaria, Falciparum (5)  ·  Leishmaniasis, Mucocutaneous (4)  ·  Encephalitis (3)  ·  Leishmaniasis (3)  ·  Leishmaniasis, Cutaneous (3)  ·  Encephalitis, Japanese (2)  ·  Encephalomyelitis, Venezuelan Equine (2)  ·  Malaria, Vivax (2)  ·  Schistosomiasis (2)  ·  Virus Diseases (2)  ·  Alphavirus Infections (1)  ·  Arrhythmias, Cardiac (1)

Broader conditions

Infections (42)  ·  Parasitic Diseases (27)  ·  Protozoan Infections (24)  ·  Mosquito-Borne Diseases (23)  ·  Arbovirus Infections (13)  ·  Euglenozoa Infections (13)  ·  RNA Virus Infections (13)  ·  Virus Diseases (11)  ·  Flaviviridae Infections (9)  ·  Flavivirus Infections (9)  ·  Central Nervous System Diseases (8)  ·  Central Nervous System Infections (8)  ·  Skin and Connective Tissue Diseases (8)  ·  Brain Diseases (7)

Interventions

Meglumine Antimoniate (4)  ·  benzonidazole (3)  ·  miltefosine (3)  ·  Ivermectin (2)  ·  Pentoxifylline (2)  ·  Prodrugs (2)  ·  Ribavirin (2)  ·  Vaccines (2)  ·  fosmidomycin (2)  ·  18-methoxycoronaridine (1)  ·  Aluminum Hydroxide (1)  ·  Artesunate (1)  ·  Azithromycin (1)  ·  Bay 44-4400 (1)  ·  Chloroquine (1)

Sponsors

Drugs for Neglected Diseases (4)  ·  U.S. Army Medical Research and Development Command (4)  ·  University of Sao Paulo General Hospital (3)  ·  Oswaldo Cruz Foundation (2)  ·  University of Brasilia (2)  ·  Vac4All (2)  ·  African Malaria Network Trust (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Butantan Institute (1)  ·  Centre Hospitalier Universitaire de la Guadeloupe (1)  ·  Centro de Investigaciones Bioclínicas de la Fundación Fader (1)  ·  Claude Bernard University (1)  ·  Elisabethinen Hospital (1)  ·  Guangzhou 8th People's Hospital (1)  ·  Hadassah Medical Organization (1)

Countries

Brazil (9)  ·  Bolivia (4)  ·  United States (4)  ·  China (3)  ·  Mali (3)  ·  Colombia (2)  ·  Israel (2)  ·  Thailand (2)  ·  Austria (1)  ·  Bangladesh (1)  ·  Czechia (1)  ·  Democratic Republic of the Congo (1)  ·  France (1)  ·  Gabon (1)  ·  Ghana (1)

Top investigators

Anthony Cardile, DO (3)  ·  Faustino Torrico, PhD (2)  ·  Alexander R Precioso, MD, PhD (1)  ·  Armando O. Schubach, MD, PhD (1)  ·  Benedito AL Fonseca, PhD (1)  ·  Caio J Fernandes, PHD (1)  ·  Claes D Enk, MD, PhD (1)  ·  Clara Menendez, MD, PhD (1)  ·  Fabio Fernandes, Md, PHD (1)  ·  Faustino Torrico, MD (1)  ·  Fengcai Zhu, Master (1)  ·  Francesco M Turrini, MD, PhD (1)

Results publications

PMID 15714427, PMID 18419347, PMID 19143532, PMID 19630971, PMID 21292874, PMID 21931708, PMID 29352704, PMID 30509941, PMID 31307503, PMID 32220283, PMID 33124646, PMID 33763778, PMID 33836161, PMID 33983371, PMID 35837409, PMID 35925555, PMID 36409773, PMID 36780676, PMID 36969244, PMID 39308445, PMID 39356094, PMID 39627222, PMID 39794472, PMID 40982532

NIH funding

2014 (1)